DETECTION AND MONITORING OF NONALCOHOLIC FATTY LIVER DISEASE

摘要

A method of assessing the severity of nonalcoholic fatty liver disease nonalcoholic steatohepatitis, and/or liver fibrosis in a subject includes obtaining a bodily sample from a subject and determining a level of the at least one oxidized fatty acid product in the sample. An increased level of at least one oxidized fatty acid product in the subject compared to a control is indicative of an increase in severity of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and/or liver fibrosis.